OCGN: Is this Popular StockTwits Company Worth The Risk?

Photo by National Cancer Institute on Unsplash

Massive Historical Shareholder Dilution for OCGN Stock Holders:

There have been various recent offerings of stock to help OCGN raise money, but what are they using this money for?

OCGN Stock Financial Position:

Typically, high growth stocks will have high dilution figures, but will have large revenue growth (even if their net income is decreasing). However, since 2020 (the start of their large dilution) OCGN’s revenues have gone from a measly $42k, to -$380, and their net income has decreased from -$34M to -$47M.

OCGN Stocktwits Talk:

To find out if there is something I am missing I decided to take a look at the messages posted in the OCGN Stocktwits to see what the retail investors see in the OCGN stock.

Overall Thoughts on OCGN Stock:

Overall, I think the best way to profit off of OCGN Stock is to short it or buy puts. I think that even if they have a large spike that their stock will fall back down below current prices within the days/weeks after a spike. Furthermore, I think the FDA news around Covaxin doesn’t really matter too much, as there are many reputable vaccines already on the market.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Utradea

Utradea

The social platform for investment ideas and insights. Check out utradea.com for the latest investment content.